Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and ultrarare genetic diseases. Its portfolio includes approved biologics and gene therapies targeting conditions like XLH, MPS VII, and HoFH. The company emphasizes efficient drug development, strategic licensing, and global commercialization to address high unmet medical needs in niche markets.
This description was generated via AI from an annual report. Updated about 1 year ago.